Dave Lemus joined as our Director in April 2022. Mr. Lemus was previously the Chief Executive Officer of Ironshore Pharmaceuticals Inc. and serves on the board of directors of Silence Therapeutics, Sorrento Therapeutics, Inc. and Biohealth Innovation, Inc. Previously, Mr. Lemus stepped down from Medigene AG’s board of directors to serve as the company’s Chief Operating Officer and Interim Chief Financial Officer. Preceding this position, he served as Chief Executive Officer of Sigma Tau Pharmaceuticals, Inc. Prior to this, he was Chief Financial Officer and executive VP of MorphoSys AG for more than 13 years, taking the company public in Germany’s first biotechnology initial public offering. Mr. Lemus received a M.S. from the Massachusetts Institute of Technology and received a B.S. from the University of Maryland. Mr. Lemus is a Certified Public Accountant in the USA, licensed in the State of Maryland.